West Virginia enacted Senate Bill 453 with the intention of improving transparency and fairness in prescription drug benefits, particularly for the Public Employees Insurance Agency (PEIA). Yet, the state’s Business Intelligence Study, completed at the end of 2024, shows that several core provisions may have unintentionally created new challenges for pharmacies, patients, and payers.
West Virginia has seen in other areas of healthcare—such as certificate of need laws—that heavily prescriptive rules restrict access and discourage investment. The findings of the Business Intelligence Study suggest that pharmacy benefit policy is now encountering similar dynamics.
Loading the full story…
